High-dose melphalan in 1 day versus over 2 days followed by autologous stem cell transplantation as consolidation treatment in patients with multiple myeloma

Original language	English
Pages (from-to)	e67-e70
Journal	British journal of haematology
Volume	196
Issue number	6
Early online date	2021
DOIs	https://doi.org/10.1111/bjh.17980 https://doi.org/10.1111/bjh.17980
Publication status	Published - Mar 2022

Consolidation Chemotherapy, Hematopoietic Stem Cell Transplantation/adverse effects, Humans, Melphalan/therapeutic use, Multiple Myeloma/drug therapy, Stem Cell Transplantation/adverse effects, Transplantation Conditioning, Transplantation, Autologous

ID: 20976424

Generic Portal